Chuck Padala | LifeSci Advisors, Investor Relations |
Dror Bashan | President & Chief Executive Officer |
Eyal Rubin | Chief Financial Officer |
Boobalan Pachaiyappan | H.C. Wainwright |
Greetings and welcome to the Protalix Biopharmaceuticals Third Quarter 2020 Financial Results and Business Update. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Investor Relations.